Literature DB >> 26781117

Probiotic-Induced Priming of Innate Immunity to Protect Against Rotaviral Infection.

Alison Thompson1, Elaine Van Moorlehem1, Palok Aich2,3.   

Abstract

Understanding of probiotic-induced regulatory gene expression and networking is critical to further explore their roles in controlling infection. Transcriptional profile of selected innate immune genes in primary bovine intestinal epithelial cells was assessed over a time course of incubation with the probiotic Lactobacillus plantarum 299v. Based on gene expression results, a time point was chosen to prime epithelial cells with the probiotic prior to infection with rotavirus. Plaque assays and genomic analysis provided the basis for establishing the efficacy of probiotics in preventing a rotaviral infection. Plaque assays revealed that the probiotic is capable of decreasing (at least by 100-fold) the levels of live virus when the cells were primed with the probiotic. Results from gene expression studies (a) suggested that homeostasis in the gut is maintained in probiotic-primed cells despite infection with rotavirus and (b) revealed preliminary mechanisms for understanding the pathway of pathogen protection by using probiotics.

Entities:  

Keywords:  Epithelial cells; Gene expression; Innate immunity; Probiotic; Rotavirus

Year:  2010        PMID: 26781117     DOI: 10.1007/s12602-009-9032-9

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  20 in total

Review 1.  Probiotics: effects on immunity.

Authors:  E Isolauri; Y Sütas; P Kankaanpää; H Arvilommi; S Salminen
Journal:  Am J Clin Nutr       Date:  2001-02       Impact factor: 7.045

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Probiotics and infectious diarrhea.

Authors:  J Saavedra
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

4.  Development of a rotavirus plaque assay using Sephadex G-75.

Authors:  P M Aha; M I Sabara
Journal:  J Virol Methods       Date:  1990-04       Impact factor: 2.014

5.  Comparative analysis of innate immune responses following infection of newborn calves with bovine rotavirus and bovine coronavirus.

Authors:  Palok Aich; Heather L Wilson; Radhey S Kaushik; Andy A Potter; Lorne A Babiuk; Philip Griebel
Journal:  J Gen Virol       Date:  2007-10       Impact factor: 3.891

Review 6.  Innate immune response to viral infection.

Authors:  Shohei Koyama; Ken J Ishii; Cevayir Coban; Shizuo Akira
Journal:  Cytokine       Date:  2008-08-09       Impact factor: 3.861

Review 7.  Probiotics, prebiotics, and synbiotics.

Authors:  Michael de Vrese; J Schrezenmeir
Journal:  Adv Biochem Eng Biotechnol       Date:  2008       Impact factor: 2.635

Review 8.  Probiotics and immunity.

Authors:  Andrea T Borchers; Carlo Selmi; Frederick J Meyers; Carl L Keen; M Eric Gershwin
Journal:  J Gastroenterol       Date:  2009-01-22       Impact factor: 7.527

Review 9.  Rotavirus.

Authors:  U D Parashar; J S Bresee; J R Gentsch; R I Glass
Journal:  Emerg Infect Dis       Date:  1998 Oct-Dec       Impact factor: 6.883

Review 10.  Enteric viral infections of calves and passive immunity.

Authors:  L J Saif; K L Smith
Journal:  J Dairy Sci       Date:  1985-01       Impact factor: 4.034

View more
  8 in total

1.  In Vitro Investigation of the Immunomodulatory Potential of Probiotic Lactobacillus casei.

Authors:  Thirugnanam Karthikeyan; Mariappan Pravin; Velusamy Shanmuganathan Muthusamy; Rajaganapathy Bharathi Raja; Baddireddi Subhadra Lakshmi
Journal:  Probiotics Antimicrob Proteins       Date:  2013-03       Impact factor: 4.609

2.  Comparative Analysis of the Effects of Two Probiotic Bacterial Strains on Metabolism and Innate Immunity in the RAW 264.7 Murine Macrophage Cell Line.

Authors:  Biswaranjan Pradhan; Dipanjan Guha; Pratikshya Ray; Debashmita Das; Palok Aich
Journal:  Probiotics Antimicrob Proteins       Date:  2016-06       Impact factor: 4.609

3.  Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease.

Authors:  Sang Bong Ahn; Dae Won Jun; Bo-Kyeong Kang; Jong Hyun Lim; Sanghyun Lim; Myung-Jun Chung
Journal:  Sci Rep       Date:  2019-04-05       Impact factor: 4.379

4.  Strain-Specific Probiotic Properties of Bifidobacteria and Lactobacilli for the Prevention of Diarrhea Caused by Rotavirus in a Preclinical Model.

Authors:  Ignasi Azagra-Boronat; Malén Massot-Cladera; Karen Knipping; Johan Garssen; Kaouther Ben Amor; Jan Knol; Àngels Franch; Margarida Castell; María J Rodríguez-Lagunas; Francisco J Pérez-Cano
Journal:  Nutrients       Date:  2020-02-15       Impact factor: 5.717

5.  Interaction of Intestinal Bacteria with Human Rotavirus during Infection in Children.

Authors:  Roberto Gozalbo-Rovira; Antonio Rubio-Del-Campo; Cristina Santiso-Bellón; Susana Vila-Vicent; Javier Buesa; Susana Delgado; Natalia Molinero; Abelardo Margolles; María Jesús Yebra; María Carmen Collado; Vicente Monedero; Jesús Rodríguez-Díaz
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

6.  Effect of probiotic bacteria on porcine rotavirus OSU infection of porcine intestinal epithelial IPEC-J2 cells.

Authors:  Danielle Leblanc; Yves Raymond; Marie-Josée Lemay; Claude P Champagne; Julie Brassard
Journal:  Arch Virol       Date:  2022-07-06       Impact factor: 2.685

7.  Noroviral p-particles as an in vitro model to assess the interactions of noroviruses with probiotics.

Authors:  Antonio Rubio-del-Campo; José M Coll-Marqués; María J Yebra; Javier Buesa; Gaspar Pérez-Martínez; Vicente Monedero; Jesús Rodríguez-Díaz
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

8.  Probiotic legacy effects on gut microbial assembly in tilapia larvae.

Authors:  Christos Giatsis; Detmer Sipkema; Javier Ramiro-Garcia; Gianina M Bacanu; Jason Abernathy; Johan Verreth; Hauke Smidt; Marc Verdegem
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.